Los puntos clave no están disponibles para este artículo en este momento.
STAR*D's cumulative remission rate was approximately half of that reported.
Pigott et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: